In this current study, because of this reason and their different genetical background (HT-29 cell line is BRAF-mutated colorectal adenocarcinoma; on the other hand, the HCT-116 cell line is KRAS-mutated colon carcinoma), we have selected these lines. The gene discussed is BRAF; the disease is colon carcinoma.